Mara A McAdams-DeMarco1,2, Andrew Law1,2, Megan L Salter1,2, Brian Boyarsky1, Luis Gimenez3,4,5, Bernard G Jaar2,3,4,5, Jeremy D Walston6, Dorry L Segev1,2. 1. Department of Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland. 2. Department of Epidemiology, School of Public Health, Johns Hopkins University, Baltimore, Maryland. 3. Nephrology Center of Maryland, Baltimore, Maryland. 4. Division of Nephrology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland. 5. Dialysis Program, Good Samaritan Hospital, Baltimore, Maryland. 6. Division of Geriatric Medicine and Gerontology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Abstract
OBJECTIVES: To quantify the prevalence of frailty in adults of all ages undergoing chronic hemodialysis, its relationship to comorbidity and disability, and its association with adverse outcomes of mortality and hospitalization. DESIGN: Prospective cohort study. SETTING: Single hemodialysis center in Baltimore, Maryland. PARTICIPANTS: One hundred forty-six individuals undergoing hemodialysis enrolled between January 2009 and March 2010 and followed through August 2012. MEASUREMENTS: Frailty, comorbidity, and disability on enrollment in the study and subsequent mortality and hospitalizations. RESULTS: At enrollment, 50.0% of older (≥ 65) and 35.4% of younger (<65) individuals undergoing hemodialysis were frail; 35.9% and 29.3%, respectively, were intermediately frail. Three-year mortality was 16.2% for nonfrail, 34.4% for intermediately frail, and 40.2% for frail participants. Intermediate frailty and frailty were associated with a 2.7 times (95% confidence interval (CI) = 1.02-7.07, P = .046) and 2.6 times (95% CI = 1.04-6.49, P = .04) greater risk of death independent of age, sex, comorbidity, and disability. In the year after enrollment, median number of hospitalizations was 1 (interquartile range 0-3). The proportion with two or more hospitalizations was 28.2% for nonfrail, 25.5% for intermediately frail, and 42.6% for frail participants. Although intermediate frailty was not associated with number of hospitalizations (relative risk = 0.76, 95% CI = 0.49-1.16, P = .21), frailty was associated with 1.4 times (95% CI = 1.00-2.03, P = .049) more hospitalizations independent of age, sex, comorbidity, and disability. The association between frailty and mortality (interaction P = .64) and hospitalizations (P = .14) did not differ between older and younger participants. CONCLUSIONS: Adults of all ages undergoing hemodialysis have a high prevalence of frailty, more than five times as high as community-dwelling older adults. In this population, regardless of age, frailty is a strong, independent predictor of mortality and number of hospitalizations.
OBJECTIVES: To quantify the prevalence of frailty in adults of all ages undergoing chronic hemodialysis, its relationship to comorbidity and disability, and its association with adverse outcomes of mortality and hospitalization. DESIGN: Prospective cohort study. SETTING: Single hemodialysis center in Baltimore, Maryland. PARTICIPANTS: One hundred forty-six individuals undergoing hemodialysis enrolled between January 2009 and March 2010 and followed through August 2012. MEASUREMENTS: Frailty, comorbidity, and disability on enrollment in the study and subsequent mortality and hospitalizations. RESULTS: At enrollment, 50.0% of older (≥ 65) and 35.4% of younger (<65) individuals undergoing hemodialysis were frail; 35.9% and 29.3%, respectively, were intermediately frail. Three-year mortality was 16.2% for nonfrail, 34.4% for intermediately frail, and 40.2% for frail participants. Intermediate frailty and frailty were associated with a 2.7 times (95% confidence interval (CI) = 1.02-7.07, P = .046) and 2.6 times (95% CI = 1.04-6.49, P = .04) greater risk of death independent of age, sex, comorbidity, and disability. In the year after enrollment, median number of hospitalizations was 1 (interquartile range 0-3). The proportion with two or more hospitalizations was 28.2% for nonfrail, 25.5% for intermediately frail, and 42.6% for frail participants. Although intermediate frailty was not associated with number of hospitalizations (relative risk = 0.76, 95% CI = 0.49-1.16, P = .21), frailty was associated with 1.4 times (95% CI = 1.00-2.03, P = .049) more hospitalizations independent of age, sex, comorbidity, and disability. The association between frailty and mortality (interaction P = .64) and hospitalizations (P = .14) did not differ between older and younger participants. CONCLUSIONS: Adults of all ages undergoing hemodialysis have a high prevalence of frailty, more than five times as high as community-dwelling older adults. In this population, regardless of age, frailty is a strong, independent predictor of mortality and number of hospitalizations.
Authors: Ruta Vaiciuniene; Vytautas Kuzminskis; Edita Ziginskiene; Inga Skarupskiene; Inga A Bumblyte Journal: J Nephrol Date: 2012 Sep-Oct Impact factor: 3.902
Authors: Jonathan Bazeley; Brian Bieber; Yun Li; Hal Morgenstern; Patricia de Sequera; Christian Combe; Hiroyasu Yamamoto; Martin Gallagher; Friedrich K Port; Bruce M Robinson Journal: Clin J Am Soc Nephrol Date: 2011-08-25 Impact factor: 8.237
Authors: J Craig Longenecker; Josef Coresh; Neil R Powe; Andrew S Levey; Nancy E Fink; Alice Martin; Michael J Klag Journal: J Am Soc Nephrol Date: 2002-07 Impact factor: 10.121
Authors: Loic Desquilbet; Joseph B Margolick; Linda P Fried; John P Phair; Beth D Jamieson; Marcy Holloway; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2009-03-01 Impact factor: 3.731
Authors: Mara A McAdams-DeMarco; Andrew Law; Jingwen Tan; Cassandra Delp; Elizabeth A King; Babak Orandi; Megan Salter; Nada Alachkar; Niraj Desai; Morgan Grams; Jeremy Walston; Dorry L Segev Journal: Transplantation Date: 2015-04 Impact factor: 4.939
Authors: Ismay N van Loon; Namiko A Goto; Franciscus T J Boereboom; Michiel L Bots; Marianne C Verhaar; Marije E Hamaker Journal: Clin J Am Soc Nephrol Date: 2017-07-17 Impact factor: 8.237
Authors: A J Nastasi; M A McAdams-DeMarco; J Schrack; H Ying; I Olorundare; F Warsame; A Mountford; C E Haugen; M González Fernández; S P Norman; D L Segev Journal: Am J Transplant Date: 2017-08-30 Impact factor: 8.086
Authors: Damani A Piggott; Ravi Varadhan; Shruti H Mehta; Todd T Brown; Huifen Li; Jeremy D Walston; Sean X Leng; Gregory D Kirk Journal: J Gerontol A Biol Sci Med Sci Date: 2015-09-18 Impact factor: 6.053
Authors: Kristen Sgambat; Matthew B Matheson; Stephen R Hooper; Bradley Warady; Susan Furth; Asha Moudgil Journal: Pediatr Nephrol Date: 2019-08-02 Impact factor: 3.714